SZLS — StageZero Life Sciences Balance Sheet
0.000.00%
HealthcareAdventurousMicro Cap
Annual balance sheet for StageZero Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2018 December 31st | C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.106 | 0.071 | 6.6 | 1.72 | 0.016 |
Net Total Receivables | 0.045 | 0.171 | 0.17 | 0.127 | 0.031 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.353 | 0.376 | 7.22 | 2.39 | 0.266 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.07 | 1.04 | 1.26 | 0.872 | 0.434 |
Net Goodwill | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1.45 | 1.96 | 8.51 | 10.6 | 0.701 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5.52 | 4.22 | 5.59 | 4.74 | 7.03 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 6.96 | 6.46 | 9.74 | 7.88 | 8.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -5.51 | -4.49 | -1.23 | 2.76 | -7.5 |
Total Liabilities & Shareholders' Equity | 1.45 | 1.96 | 8.51 | 10.6 | 0.701 |
Total Common Shares Outstanding |